​

BeOne Medicines Ownership | Who Owns BeOne Medicines?


OverviewForecastRevenueFinancialsChartTranscripts

BeOne Medicines Ownership Summary


BeOne Medicines is owned by 32.90% institutional investors, 17.28% insiders, and 49.82% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 7.93% of ONC shares. American Funds New Perspective A is the top mutual fund, with 2.67% of its assets in BeOne Medicines shares.

ONC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeOne Medicines32.90%17.28%49.82%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp8.80M7.93%$2.51B
Primecap management co/ca/4.91M4.40%$1.80B
Capital investors4.61M4.13%$1.69B
Capital world investors3.90M3.50%$1.43B
Fmr2.32M2.08%$849.70M
Thomas j. herzfeld advisors2.05M1.86%$29.00M
Citadel advisors1.43M1.28%$406.23M
Blackrock funding, inc. /de804.09K0.72%$294.25M
Price t rowe associates inc /md/758.75K0.68%$216.22M
Morgan stanley665.26K0.60%$243.45M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp8.80M12.57%$2.51B
Thomas j. herzfeld advisors2.05M9.81%$29.00M
Siren465.00K4.02%$170.16M
Nan fung group15.72K3.84%$5.75M
Healthinvest partners ab35.68K3.50%$13.06M
Superstring capital management lp12.27K2.21%$3.50M
Patient square capital lp33.50K1.96%$12.26M
Jgp global gestao de recursos ltda.1.71K1.27%$626.12K
Slow capital27.84K1.15%$10.19M
Primecap management co/ca/4.91M1.11%$1.80B

Top Buyers

HolderShares% AssetsChange
Thomas j. herzfeld advisors2.05M9.81%2.05M
Capital world investors3.90M0.17%1.65M
Capital investors4.61M0.35%398.69K
Citadel advisors1.43M0.05%393.22K
Millennium management543.32K0.06%338.48K

Top Sellers

HolderShares% AssetsChange
Hhlr advisors---1.03M
Temasek (private)205.47K0.20%-640.26K
Marshall wace, llp5.56K0.00%-172.42K
Fmr2.32M0.04%-156.57K
Nuveen79.08K0.01%-121.98K

New Positions

HolderShares% AssetsChangeValue
Thomas j. herzfeld advisors2.05M9.81%2.05M$29.00M
North ground capital135.32K0.95%135.32K$1.91M
Arete wealth advisors99.33K0.09%99.33K$1.40M
Resources investment advisors, llc.97.13K0.01%97.13K$1.37M
Advisors asset management64.26K0.02%64.26K$908.58K

Sold Out

HolderChange
Hm payson-2.00
Twin peaks wealth advisors-2.00
Westside investment management-2.00
Stone house investment management-3.00
Central trust-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202633512.79%36,707,5084.96%323.35%20417.24%7413.85%
Jun 30, 2026294-0.68%34,973,1370.45%313.09%17123.91%66-32.65%
Mar 31, 2026290-19.22%34,397,333-32.01%311.50%136-41.38%9734.72%
Dec 31, 2025154-44.80%12,358,898-62.55%111.25%87-43.87%40-48.72%
Sep 30, 202527910.71%32,997,831-4.21%292.97%15530.25%78-8.24%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds New Perspective A3.04M2.67%371.54K
Capital Group New Perspective Comp2.66M2.39%-
Vanguard PRIMECAP Inv2.30M2.02%-46.20K
Vanguard Capital Opportunity Inv1.17M1.03%-12.00K
American Funds New Economy A972.97K0.86%481.21K
NT Emerg Markets Index Fund - NL824.27K0.74%-41.00K
Fidelity Growth Compy Commingled Pl S828.16K0.73%-
American Funds Fundamental Invs A808.97K0.71%808.97K
Capital Group EUPAC Composite700.82K0.63%-29.57K
Fidelity Contrafund698.37K0.63%-36.93K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 06, 2026Ball Titus B. Principal Accounting OfficerSell$621.71K
Nov 06, 2026Ball Titus B. Principal Accounting OfficerSell$10.56K
Nov 05, 2026Lee Chan Henry SVP, General CounselSell$264.00K
Nov 05, 2026Lee Chan Henry SVP, General CounselSell$182.91K
Oct 27, 2026Wang Xiaodong Chair, Scientific Advisory BrdSell$603.05K

Insider Transactions Trends


DateBuySell
2026 Q4-16
2026 Q3-111
2026 Q2-40
2026 Q1-4
2025 Q4-47

ONC Ownership FAQ


Who Owns BeOne Medicines?

BeOne Medicines shareholders are primarily institutional investors at 32.90%, followed by 17.28% insiders and 49.82% retail investors. The average institutional ownership in BeOne Medicines's industry, Biotech Stocks , is 181.71%, which BeOne Medicines falls below.

Who owns the most shares of BeOne Medicines?

BeOne Medicines’s largest shareholders are Baker bros. advisors lp (8.8M shares, 7.93%), Primecap management co/ca/ (4.91M shares, 4.40%), and Capital investors (4.61M shares, 4.13%). Together, they hold 16.46% of BeOne Medicines’s total shares outstanding.

Does Blackrock own BeOne Medicines?

BlackRock is not among the top 10 institutional shareholders of BeOne Medicines.

Who is BeOne Medicines’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is BeOne Medicines’s biggest shareholder by percentage of total assets invested, with 12.57% of its assets in 8.8M BeOne Medicines shares, valued at 2.51B$.

Who is the top mutual fund holder of BeOne Medicines shares?

American Funds New Perspective A is the top mutual fund holder of BeOne Medicines shares, with 2.67% of its total shares outstanding invested in 3.04M BeOne Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools